Answer questions and earn CME/CNE Laryngeal cancer remains one of the most common
tumors of the respiratory tract. Fortunately, significant advancements have been made over …

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Head and Neck
Cancers provide treatment recommendations for cancers of the lip, oral cavity, pharynx …

The measurement of patient-reported outcome measures (PROMs) following head and neck
cancer (HNC) has the capacity to substantially enhance the care of patients and their care …

Abstract Background B490 (EudraCT# 2011-002564-24) is a randomized, phase 2b,
noninferiority study investigating the efficacy and safety of first-line cetuximab plus cisplatin …

Background Activating events along the PI3K/mTOR pathway are common in head and neck
squamous cell carcinomas (HNSCC), and preclinical studies suggest additive or synergistic …

Head and neck cancer, treated or untreated, can cause significant morbidity and mortality.
Patients can experience severe impairments, both from the cancer and the treatments. Of all …

Purpose To report a single-institutional experience using magnetic resonance imaging
(MRI) guided radiation therapy for the reirradiation of recurrent and second cancers of the …

Chewing areca nut is closely associated with oral squamous cell carcinoma (OSCC). The
current study aimed to investigate potential associations between areca nut extract (ANE) …

Chemotherapy is the only option of treatment for most patients presenting with a recurrent
and/or metastatic head and neck squamous cell carcinoma. The triple association of …

Background Cetuximab, an anti-EGFR monoclonal antibody in combination with platinum
and 5FU is the standard of care in first-line treatment of patients with recurrent head and …